ALIVUS / NSE / Biotechnology & Drugs
Alivus Life Sciences
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High1,193.3
Target Low830
Target Mean1.5
Target Median62.5
Risk Metrics
Overall RiskBalanced risk
Board Risk26.27
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Alivus Life Sciences schedules investor meets for June 09 scanx.trade
Half Yearly Results, Half yearly Earnings for Glenmark Life The Economic Times
Number of shareholders of Alivus Life Sciences Ltd – NSE:ALIVUS TradingView
Alivus Life Sciences Downgraded to Hold Amid Mixed Technical and Valuation Signals Markets Mojo
Alivus Life Sciences Ltd Sees Shift in Technical Momentum Amid Mixed Indicator Signals Markets Mojo
Alivus Life Sciences Ltd Surges 7.06% to Day's High of Rs 1123 — Outperforms Sector by 7.21 Percentage Points Markets Mojo
Stock FAQs
What is the symbol and ISIN of Alivus Life Sciences?
Alivus Life Sciences has the symbol ALIVUS and ISIN - INE03Q201024.
What is the current price of Alivus Life Sciences?
Alivus Life Sciences is currently trading at INR 1,159.90.
What are the year high and year low of Alivus Life Sciences?
Alivus Life Sciences has a year high of INR 1,193.30 and a year low of INR 830.00.
What is the market capitalization of Alivus Life Sciences?
Alivus Life Sciences has a market capitalization of INR 14,203.34 crore.
What is the P/E ratio of Alivus Life Sciences?
Alivus Life Sciences has a P/E ratio of 21.15.
What is the dividend yield of Alivus Life Sciences?
Alivus Life Sciences has a dividend yield of 0.44%.
How is the financial performance of Alivus Life Sciences based on revenue, net income, and EPS?
Alivus Life Sciences has revenue of INR 25,518.32 crore, net income of INR 5,644.83 crore, and EPS of INR 47.48.
What is the book value of Alivus Life Sciences?
Alivus Life Sciences has a book value of INR 269.05.
What is the debt-to-equity ratio of Alivus Life Sciences?
Alivus Life Sciences has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Alivus Life Sciences?
Alivus Life Sciences has a price-to-book ratio of 4.31 and a price-to-sales ratio of 0.56.
© SharekeyX | Rusaka Technologies 2024-2026

